Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Imaging biomarkers of lung ventilation in interstitial lung disease from 129Xe and oxygen enhanced 1H MRI

Magnetic Resonance Imaging(2022)10.1016/j.mri.2022.10.005Source: DataRank Database

Imaging biomarkers of lung ventilation in interstitial lung disease from 129Xe and oxygen enhanced 1H MRI is a research paper published in Magnetic Resonance Imaging (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 1.29)OA: hybridTopics (36)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

James Eaden ORCID,Josephine H. Naish ORCID,Paul Hughes ORCID,John C. Waterton ORCID,Matthew J. Heaton ORCID

Live enrichment

PubMed:36252693 OpenAlex:https://openalex.org/W4306319281

Innovative Medicines Initiative

Grant: 116106

Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

GlaxoSmithKline

Grant: BIDS3000032592

Medical Research Council

Grant: MR/M008894/1

Expansion of state-of-the-art MR imaging infrastructure for pulmonary disease stratification: POLARIS

National Institute for Health Research (NIHR)

Grant: NF-SI-0512-10105

National Institute for Health Research (NIHR)

Grant: RP-R3-12-027

National Institute for Health Research (NIHR)

Grant: NF-SI-0617-10075

British Heart Foundation

Grant: SP/14/6/31350

European Federation of Pharmaceutical Industries and Associations

National Institute for Health and Care Research

European Commission

GlaxoSmithKline

National Institute for Health Research (NIHR)

FWCI

1.29

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://www.sciencedirect.com/science/article/pii/S0730725X22001771/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S0730725X22001771/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0730725X22001771?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0730725X22001771?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.mri.2022.10.005

Fields of Study

Atomic and Subatomic Physics ResearchInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansLungMagnetic Resonance ImagingOxygenProspective StudiesBiomarkersLung Diseases, InterstitialIdiopathic Pulmonary Fibrosis

Keywords

MedicineInterstitial lung diseaseSpirometryHypersensitivity pneumonitisIdiopathic pulmonary fibrosisMagnetic resonance imagingVentilation (architecture)Pulmonary function testingLungInternal medicineRadiologyCardiologyNuclear medicineLung MriOxygen Enhanced MriHyperpolarised Gas MriLung DiseasesOxygenHumansProspective StudiesInterstitialLung Diseases, InterstitialBiomarkers

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being